Using Mixed Methods Research in Children with Type 1 Diabetes: a Methodological Review

Sara L Davis1, Sarah S Jaser2, Nataliya V Ivankova3

  • 1Maternal Child Health Nursing, University of South Alabama, 5721 USA Dr N, Mobile, AL, 36688, USA. saradavis@southalabama.edu.

Insights

Mixed methods research (MMR) uniquely examines factors affecting type 1 diabetes (T1D) management in children. Limited studies exist, but future MMR could improve glycemic control and health outcomes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Diabetes Research

Background:

  • Type 1 diabetes (T1D) management in children involves complex factors influencing glycemic control.
  • Traditional research methods (qualitative or quantitative) have limitations in studying these intricate aspects in pediatric populations.
  • Mixed methods research (MMR) provides innovative approaches for investigating complex questions in children with T1D and their families.

Purpose of the Study:

  • To review and synthesize existing empirical mixed methods research (MMR) studies involving children with T1D.
  • To identify themes, trends, and inconsistencies in the application of MMR in pediatric T1D research.
  • To highlight the potential of MMR to enhance understanding and management of T1D in children.

Main Methods:

  • A focused, methodological literature review was conducted.
  • Twenty empirical MMR studies including children with T1D and/or their caregivers were identified and analyzed.
  • Synthesis of findings to elicit common themes and methodological trends.

Main Results:

  • Key themes identified in the reviewed MMR studies were disease management, intervention evaluation, and support systems.
  • Significant inconsistencies were found in the reporting of MMR definitions, rationales, and study designs across the literature.
  • A limited number of studies currently employ MMR to investigate concepts pertinent to children with T1D.

Conclusions:

  • MMR offers a valuable framework for studying complex issues in pediatric T1D management.
  • Addressing inconsistencies in MMR reporting is crucial for future research.
  • Future MMR studies, particularly those incorporating child-reported data, hold promise for improving disease management and glycemic outcomes in children with T1D.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
322
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
219
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K